Literature DB >> 31169569

Deprescribing at the end of life in older patients.

Matthew J Stinson1, Samuel Gurevitz, Anna Carrigan.   

Abstract

In the United States, the adult population that will need hospice and palliative care is expected to double in the next 40 years. In primary care, providers are often faced with tough decisions on how to manage patients' medications at the end of life. This article describes how to deprescribe in the last year of life.

Entities:  

Mesh:

Year:  2019        PMID: 31169569     DOI: 10.1097/01.JAA.0000558316.40245.ca

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  2 in total

1.  Evaluation of an Interprofessional Academic-Practice Partnership in End of Life Care.

Authors:  Katie F Leslie; M Kate Probst; Taylor L Hawkins
Journal:  Innov Pharm       Date:  2021-09-22

2.  Deprescribing in Hospice Patients: Discontinuing Aspirin, Multivitamins, and Statins.

Authors:  Cari E Low; Daniel E Sanchez Pellecer; Wil L Santivasi; Virginia H Thompson; Theresa Elwood; Ashly J Davidson; Julie A Tlusty; Molly A Feely; Cory Ingram
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.